Ground breaking medical innovation, better patient outcomes, strong financial returns.
————
Investmed has been effective in raising successive funds that collectively cover the spectrum of life science venture investing. We also have a co-investment arrangement with our investors, providing significant capacity to support our advancing portfolio companies.
0
+active portfolio companies
0
+Investors and Venture Partners spanning Australia, New Zealand, United States and the United Kingdom
Investment
————Portfolio
Understanding the dedication needed to bring a great idea to market, we collaborate closely with entrepreneurs for the long term. By supporting the development and commercialisation of their technologies, we create value for their teams, deliver returns for our investors, and ultimately improve outcomes for patients.
We prefer to invest early and have served as the founding investor for the majority of our current portfolio companies.
- Aravax
- Axelia
- Azura Ophthalmics
- CatalYm
- Certa Therapeutics
- Denteric
- Entact Bio